(Total Views: 386)
Posted On: 03/07/2021 7:35:53 PM
Post# of 148988
“ Canada seems to understand what LLMab can do and is moving to secure a supply. Can't say the US FDA didn't have their chance.”
Read More: https://investorshangout.com/post/view?id=607...z6oTWS474f
I did not hear encouraging news in the DRBEEN interview re Canada. NP said the pathway there required that they open a trial site in Canada. It sounded like he just learned of this requirement, which is also disquieting.
UK sounded more promising, but I couldn’t tell if discussions concern our data and encouraging response from UK or was just a summary of UK process applicable to all comers.
I hate to sound negative, but the whole “we’re gonna submit the data for publication” sounds like we aren’t going to see it for a long time.
I am holding my shares and hoping tomorrow’s provides clearer answers about our results and status of HIV BLA application. I bought into CYDY for HIV and I want to see that through. Give us specifics about the HIV BLA.
Read More: https://investorshangout.com/post/view?id=607...z6oTWS474f
I did not hear encouraging news in the DRBEEN interview re Canada. NP said the pathway there required that they open a trial site in Canada. It sounded like he just learned of this requirement, which is also disquieting.
UK sounded more promising, but I couldn’t tell if discussions concern our data and encouraging response from UK or was just a summary of UK process applicable to all comers.
I hate to sound negative, but the whole “we’re gonna submit the data for publication” sounds like we aren’t going to see it for a long time.
I am holding my shares and hoping tomorrow’s provides clearer answers about our results and status of HIV BLA application. I bought into CYDY for HIV and I want to see that through. Give us specifics about the HIV BLA.
(0)
(0)Scroll down for more posts ▼
